Multimodal Retinal Imaging for the Detection of Early Alzheimer's Disease: Combining Biochemical, Structural, and Vascular Biomarkers
Bioengineering
Abstract
Alzheimer's disease (AD) pathology is increasingly recognized to manifest in the retina, offering a non-invasive window for early biomarker discovery.
- Multimodal retinal imaging
- Alzheimer's disease
- Dementia
- Mild cognitive impairment
- GC-IPL thickness
- Humans
The paper
Michiel Ghesquiere, Eirini Christinaki, Sophie Lemmens, Ingeborg Stalmans
Show 17 more authors
Jan Van Eijgen, Lennert Beeckmans, Achilleas Ghinis, Thomas Jacobs, Karel V Keer, Zahi Wehbi, Lies De Groef, Yasmin Dahdouh-Guebas, Wouter Charle, Thomas Vande Casteele, Mathieu Vandenbulcke, Greet Vanderlinden, Koen Van Laere, Jolien M. Schaeverbeke, Rik Vandenberghe, Jenny Ceccarini, Maarten De Vos,Bioengineering · 8 Sep 2026 · CC BY
